You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 826 Risk of COVID-19 infection among patients receiving immune checkpoint inhibitor therapy: a tertiary care hospital system collaboration with the Massachusetts department of health

Article metrics

Article menu

Download PDFPDF

Late-breaking abstracts
COVID and immunotherapy
826 Risk of COVID-19 infection among patients receiving immune checkpoint inhibitor therapy: a tertiary care hospital system collaboration with the Massachusetts department of health

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 202099015
Dec 20204805
Jan 20211404
Feb 20211402
Mar 20213207
Apr 20212804
May 2021505
Jun 2021007
Jul 2021002
Aug 2021005
Sep 2021006
Oct 202118021
Nov 20212809
Dec 20211603
Jan 20221602
Feb 20221204
Mar 20221602
Apr 20224804
May 20221409
Jun 20221806
Jul 20221402
Aug 20222803
Sep 202216010
Oct 20221603
Nov 20221004
Dec 20221203
Jan 20231205
Feb 20231601
Mar 2023601
Apr 20231401
May 2023800
Jun 2023201
Jul 20231007
Aug 2023400
Sep 2023201
Oct 20231002
Nov 20231601
Dec 20233000
Jan 20241401
Feb 20242003
Mar 202410020
Apr 202414012
May 20241008
Jun 20241605
Jul 20243404
Aug 2024802
Sep 20241003
Oct 20241806
Nov 2024803
Total8140234